| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), LIANY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Gu Ehong | Interim CFO | Sell | 1,731 | $4.34 | $7,512.54 | -2.2% | |
| Jan 3, 2023 | Qian Jiang | SVP, China General Manager | Sell | 2,239 | $1.65 | $3,701.51 | -3.2% | |
| Aug 18, 2022 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 998,240 | $2.40 | $2,395,776.00 | +36.6% | |
| May 26, 2022 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 69,000 | $3.13 | $215,970.00 | +2.6% | |
| May 25, 2022 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 171,251 | $2.58 | $442,363.97 | +6.9% | |
| Nov 3, 2021 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 2,270,000 | $15.98 | $36,270,200.00 | +8.9% | |
| Nov 2, 2021 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 220,000 | $14.59 | $3,210,000.00 | +3.1% |